Image

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

Testing mRNA-2808 for relapsed or hard-to-treat multiple myeloma.

Recruiting
18 years and older
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

Study Overview: This research is about testing a new medicine called mRNA-2808 for people with a type of blood cancer known as multiple myeloma. This study is looking at people whose cancer has come back (relapsed) or didn't get better with other treatments (refractory). We want to see if this medicine is safe and if people can handle taking it.

  • Participation: Participants must have previously tried other medicines for multiple myeloma.
  • Exclusions: Certain health conditions and recent treatments may disqualify you from participating.
  • Commitment: There may be several visits and specific criteria to meet for participation.

Key Terms:
- RRMM: Relapsed or Refractory Multiple Myeloma, meaning the cancer has returned or is not responding to treatment.
- Monoclonal Antibody: A type of medicine made to target specific cells in the body, such as cancer cells.
- Proteasome Inhibitor and Immunomodulatory Drug (IMiD): These are types of medicines used to treat multiple myeloma.
- Corticosteroid Therapy: A treatment that uses steroids to reduce inflammation and suppress the immune system.

Discuss with your doctor to see if this study might be right for you.

Print
Study details
    Relapsed or Refractory Multiple Myeloma

NCT07116616

ModernaTX, Inc.

6 June 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.